371 related articles for article (PubMed ID: 34136020)
1. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis.
Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P
Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020
[TBL] [Abstract][Full Text] [Related]
2. High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population.
Liu W; Sigdel KR; Wang Y; Su Q; Huang Y; Zhang YL; Chen J; Duan L; Shi G
PLoS One; 2015; 10(7):e0132855. PubMed ID: 26182343
[TBL] [Abstract][Full Text] [Related]
3. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
Mediwake R; Isenberg DA; Schellekens GA; van Venrooij WJ
Ann Rheum Dis; 2001 Jan; 60(1):67-8. PubMed ID: 11114286
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
Maksymowych WP; Boire G; van Schaardenburg D; Wichuk S; Turk S; Boers M; Siminovitch KA; Bykerk V; Keystone E; Tak PP; van Kuijk AW; Landewé R; van der Heijde D; Murphy M; Marotta A
J Rheumatol; 2015 Sep; 42(9):1587-94. PubMed ID: 26178283
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum soluble CD27 levels are associated with both disease activity and humoral immune activity in patients with rheumatoid arthritis.
Shi L; Yang J; Xu J; Dai J; Li J
Clin Exp Rheumatol; 2024 May; 42(5):983-990. PubMed ID: 38179730
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
Yang CL; Zhou YR; Zhou F; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
10. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
Yang X; Lin K; Ni S; Wang J; Tian Q; Chen H; Brown MA; Zheng K; Zhai W; Sun L; Jin S; Wang J
Arthritis Res Ther; 2017 Nov; 19(1):257. PubMed ID: 29166915
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
[TBL] [Abstract][Full Text] [Related]
12. Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis.
Al-Mughales JA
J Immunol Res; 2015; 2015():604305. PubMed ID: 25883991
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
Heidari B; Firouzjahi A; Heidari P; Hajian K
Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
[TBL] [Abstract][Full Text] [Related]
14. [Significance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritis].
Xu J; Liu J; Zhu L; Zhang XW; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):942-946. PubMed ID: 27987494
[TBL] [Abstract][Full Text] [Related]
15. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
16. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
Zhao Y; Li J; Li XX; Li C; Li L; Li ZG
Joint Bone Spine; 2009 Oct; 76(5):501-7. PubMed ID: 19289297
[TBL] [Abstract][Full Text] [Related]
17. [Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis].
Jin YJ; Sun L; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):631-635. PubMed ID: 37534643
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
19. Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.
Guan SZ; Yang YQ; Bai X; Wang Y; Feng KQ; Zhang HJ; Dong M; Yang HW; Li HQ
Ann Clin Lab Sci; 2019 Jan; 49(1):57-62. PubMed ID: 30814078
[TBL] [Abstract][Full Text] [Related]
20. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]